Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Masuda

Showing results (171-180 of 277) with videos related to

Pageof 28
Sort By:
Cancer|April 15, 1990
Combination chemotherapy with or without radiation therapy in small cell lung cancer. An analysis of a 5-year follow-upM Fukuoka, N Masuda, K Matsui, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Combination therapy with bestatin in inoperable lung cancer. A randomized trialM Takada, M Fukuoka, S Negoro, et al.
Anticancer Research|January 19, 1999
Prognostic significance of CYFRA 21-1 in non-small cell lung cancerT Hirashima, M Takada, T Komiya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycinM Fukuoka, N Masuda, K Furuse, et al.
Journal of Cardiovascular Pharmacology|February 1, 1994
Pharmacologic profiles of YM934, a novel potassium channel openerW Uchida, N Masuda, T Taguchi, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1994
Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aortaW Uchida, Y Hirano, Y Shirai, et al.
Cancer|July 15, 1991
A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancerM Fukuoka, N Masuda, S Negoro, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disordersM Fukuoka, S Negoro, N Masuda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2009
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapyM Maemondo, N Masuda, I Sekine, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Chemotherapy of small cell lung cancer]M Fukuoka, S Negoro, M Takada, et al.
Pageof 28

Showing results (171-180 of 277) with videos related to

Sort By:
Pageof 28
Cancer|April 15, 1990
Combination chemotherapy with or without radiation therapy in small cell lung cancer. An analysis of a 5-year follow-upM Fukuoka, N Masuda, K Matsui, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Combination therapy with bestatin in inoperable lung cancer. A randomized trialM Takada, M Fukuoka, S Negoro, et al.
Anticancer Research|January 19, 1999
Prognostic significance of CYFRA 21-1 in non-small cell lung cancerT Hirashima, M Takada, T Komiya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycinM Fukuoka, N Masuda, K Furuse, et al.
Journal of Cardiovascular Pharmacology|February 1, 1994
Pharmacologic profiles of YM934, a novel potassium channel openerW Uchida, N Masuda, T Taguchi, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1994
Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aortaW Uchida, Y Hirano, Y Shirai, et al.
Cancer|July 15, 1991
A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancerM Fukuoka, N Masuda, S Negoro, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disordersM Fukuoka, S Negoro, N Masuda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2009
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapyM Maemondo, N Masuda, I Sekine, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Chemotherapy of small cell lung cancer]M Fukuoka, S Negoro, M Takada, et al.
Pageof 28